Skip to main content
Frontiers in Molecular Biosciences logoLink to Frontiers in Molecular Biosciences
. 2025 May 9;12:1601841. doi: 10.3389/fmolb.2025.1601841

Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats

Maha Abdullah Alwaili 1, Amal S Abu-Almakarem 2, Salwa Aljohani 3, Sahar Abdulrahman Alkhodair 4, Maha M Al-Bazi 4, Thamir M Eid 4, Jehan Alamri 5, Maysa A Mobasher 6, Norah K Algarzae 7, Arwa Ishaq A Khayyat 8, Luluah Saleh Alshaygy 8, Karim Samy El-Said 9,*
PMCID: PMC12098949  PMID: 40417061

In the published article, an Author Name was incorrectly written as Norah K. Algarza. The correct spelling is Norah K. Algarzae.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Molecular Biosciences are provided here courtesy of Frontiers Media SA

RESOURCES